Cannabis stocks mostly higher as sector braces for FDA hearing on rules for CBD
Cannabis stocks mostly higher as sector
braces for FDA hearing on rules for CBD
Cannabis stocks were mostly higher Tuesday, as investors braced for a Thursday hearing by the U.S. Food and Drug Administration on how to regulate cannabis and its popular ingredient, CBD.
Story continues